The Directorate General of Trade Remedies (DGTR), operating under the Ministry of Commerce & Industry, has announced a revised list of stakeholders engaged in the current anti-dumping examination related to the importation of polytetrafluoroethylene (PTFE) from China and Russia. Polytetrafluoroethylene, […]
### Policy Development for Safe Disposal Practices The Pharmaceuticals Department (DoP) is actively working on establishing a ‘Safe Disposal Policy’ aimed at effectively removing expired and unused medications from retail outlets and domestic spaces. To facilitate this, a specialized committee
Crafting a Policy for Safe Drug Disposal Read More »
Emcure Pharmaceuticals, a prominent player in the women’s healthcare sector, celebrated a remarkable achievement on World Diabetes Day by securing a place in the Asia Book of Records. The company orchestrated the largest virtual campaign focused on women’s diabetes awareness,
Emcure Pharma’s SAKHI Diabetes Awareness Initiative Earns Spot in Asia Book of Records Read More »
**Alnylam Pharmaceuticals, Renowned RNAi Therapy Leader, Unveils Promising Phase 1 Outcomes for Nucresiran** Alnylam Pharmaceuticals, a front-runner in the field of RNA interference (RNAi) therapeutics, disclosed the latest findings from its phase 1 research on nucresiran (previously known as ALN-TTRsc04),
Boston Scientific Corporation unveiled promising outcomes from the OPTION global clinical study involving the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device, sharing three years of primary endpoint results. The study, which contrasted the device with initial oral anticoagulation (OAC)
BioCryst Pharmaceuticals, Inc., a leading biotech firm, revealed that Ireland’s Health Services Executive (HSE) has endorsed Orladeyo (berotralstat) for the regular prevention of repeated hereditary angioedema (HAE) attacks in suitable patients aged 12 and above. This endorsement enables Irish HAE
LIfT BioSciences, a leading-edge biotech firm gearing up to kick off clinical trials for its novel allogeneic innate cell therapy, has unveiled its latest expansion in manufacturing and clinical activities with the establishment of its Galway-based subsidiary, Eolaíocht Bhitheach LIfT
**EnteroBiotix, Ltd.**, a biotechnology firm at the clinical stage, specializing in advanced microbiome therapeutics, has announced the fulfillment of participant recruitment for their phase 2 TrIuMPH clinical trial. This study is evaluating the safety, tolerability, and effectiveness of EBX-102-02, their
EnteroBiotix Completes Phase 2 TrIuMPH Patient Enrollment for EBX-102-02 in IBS Study Read More »
Abbott, a leader in the global healthcare industry, has celebrated the grand opening of its advanced manufacturing facility in Kilkenny, Ireland. The event was attended by An Taoiseach, Simon Harris, TD, alongside Abbott’s chairman and CEO, Robert Ford. This site
Abbott Launches Cutting-Edge Global Production Facility in Kilkenny, Ireland Read More »
In a strategic push to address tuberculosis (TB) while considering the impacts of climate change, Molbio Diagnostics, a pioneer in global healthcare innovation, has made a significant donation of advanced TB screening and diagnostic tools to Azerbaijan’s Ministry of Health.